Immunogenicity 12215
Sample ID
3926
Response
Negative
Tumor Type
Melanoma
Gene Symbol
SLC4A8
Transcript ID
uc010snk.2
HLA INFO
A*01:01
TCR INFO
No TCR info found!
Full length protein sequence (747 aa)
MPLGR
1
QSHRH
6
HRTHG
11
QKHRR
16
RGRGK
21
GASQG
26
EEGLE
31
ALAHD
36
TPSQR
41
VQFIL
46
GTEED
51
EEHVP
56
HELFT
61
ELDEI
66
CMKEG
71
EDAEW
76
KETAR
81
WLKFE
86
EDVED
91
GGERW
96
SKPYV
101
ATLSL
106
HSLFE
111
LRSCL
116
INGTV
121
LLDMH
126
ANSIE
131
EISDL
136
ILDQQ
141
ELSSD
146
LNDSM
151
RVKVR
156
EALLK
161
KHHHQ
166
NEKKR
171
NNLIP
176
IVRSF
181
AEVGK
186
KQSDP
191
HLMDK
196
HGQTV
201
SPQSV
206
PTTNL
211
EVKNG
216
VNCEH
221
SPVDL
226
SKVDL
231
HFMKK
236
IPTGA
241
EASNV
246
LVGEV
251
DILDR
256
PIVAF
261
VRLSP
266
AVLLS
271
GLTEV
276
PIPTR
281
FLFIL
286
LGPVG
291
KGQQY
296
HEIGR
301
SMATI
306
MTDEI
311
FHDVA
316
YKAKE
321
RDDLL
326
AGIDE
331
FLDQV
336
TVLPP
341
GEWDP
346
SIRIE
351
PPKNV
356
PSQEK
361
RKMPG
366
VPNGN
371
VCHIE
376
QEPHG
381
GHSGP
386
ELQRT
391
GRLFG
396
GLVLD
401
IKRKA
406
PWYWS
411
DYRDA
416
LSLQC
421
LASFL
426
FLYCA
431
CMSPV
436
ITFGG
441
LLGEA
446
TEGRI
451
SAIES
456
LFGAS
461
MTGIA
466
YSLFA
471
GQALT
476
ILGST
481
GPVLV
486
FEKIL
491
FKFCK
496
DYALS
501
YLSLR
506
ACIGL
511
WTAFL
516
CIVLV
521
ATDAS
526
SLVCY
531
ITRFT
536
EEAFA
541
SLICI
546
IFIYE
551
AIEKL
556
IHLAE
561
TYPIH
566
MHSQL
571
DHLSL
576
YYCRC
581
TLPEN
586
PNNHT
591
LQYWK
596
DHNIV
601
TAEVH
606
WANLT
611
VSECQ
616
EMHGE
621
FMGSA
626
CGHHG
631
PYTPD
636
VLFWS
641
CILFF
646
TTFIL
651
SSTLK
656
TFKTS
661
RYFPT
666
RMESC
671
SVAWL
676
ECGGV
681
ILAHC
686
NLRLL
691
PSSWD
696
YRHAP
701
PQPAN
706
FCIFS
711
RDGVS
716
PCWPG
721
WSQSL
726
DLVIC
731
LPRPP
736
KMLGL
741
QA
746
Mutation Information
DNA mutation:
None
Peptide Range:
442 ~ 466
Mut AA position:
454 (13 in Wild Type peptide)
Alignment
Wild Type:
"TFGGLLGEATEGRISAIESLFGASM
||||||||||||.||||||||||||
Mutant:
TFGGLLGEATEGCISAIESLFGASM"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) SLC4A8
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay